Associate Director, Supply Chain

About Civica: Over the past two decades, shortages of generic, injectable medications critical to the lifesaving work of hospitals in the United States have become commonplace and have reached an all time high.

Over 300 essential medications are reported to be in shortage, according to industry and FDA reports. “Race to the bottom” pricing of mostly sterile injectable medications, manufacturing challenges and predatory pricing are both the causes and results. Who suffers most? Patients. Civica is a 501(c)(4) social welfare organization established in 2018 by health systems (CommonSpirit Health, HCA Healthcare, Intermountain Healthcare, Mayo Clinic, Providence St.

Joseph Health, SSM Health, and Trinity Health) and philanthropies (Gary and Mary West Foundation, Laura and John Arnold Foundation, and Peterson Center on Healthcare) to reduce chronic generic drug shortages and related high prices in the United States. An experienced team of health care and pharmaceutical industry leaders leads the organization. Today, more than 55 health systems have joined Civica.

They represent over 1,500 hospitals and over 30 percent of all U.S. hospital beds. Civica has also supplied the U.S.

Department of Veteran’s Affairs, the U.S.

Department of Defense, and the U.S. Strategic National Stockpile of essential medicines. Since established, the 1 Policy for the Civica team has been “Do What Is in the Best Interest of Patients.” Civica has expanded its mission beyond the hospital setting to include lowering the cost of medications at the pharmacy counter.

It has launched a sister organization, CivicaScript, to enter the retail pharmacy market partnering with Blue Cross Blue Shield entities and others with the goal of reducing select high cost generic drugs where market forces are not working to control drug costs. More recently, Civica announced plans to develop, manufacture and deliver affordable biosimilar insulin, The consistent availability of affordable insulin will benefit people who ration their care or who have been forced to choose between this life-sustaining medicine and living expenses. Those who are uninsured or underinsured often pay the most out of pocket for their medications.

Long- and short-acting insulins will be produced and available in both vials and pre-filled pens – at no more than $30 per vial and no more than $55 for a pack of five pens. Learn more about Civica’s plans and progress at www.civicarx.org Job Description: The Associate Director, Supply Chain is responsible for managing procurement and planning activities for the Civica Petersburg manufacturing site, along with supporting the relationship and flow of product from Civica CMOs (contract manufacturing organizations) and private label distribution (PLD) partners.

This includes acting as the main point of contact for relationship management and issue resolution with Civica 3PL (third party logistics) providers for storing raw materials and finished goods. Through successful management of these relationships, this person will achieve overall Civica product fulfillment commitments (quality, cost, and service) to all Civica members to meet Civica’s objective of doing what is in the best interest of patients. Essential Duties and Responsibilities:

The essential functions include, but are not limited to the following: Develop, foster, and own positive, productive relationships with all Civica CMOs, PLD partners, and 3PL providers. Manage the flow of product at the Civica Petersburg manufacturing site, from procurement of raw materials, through supply planning, and successful delivery to Civica finished goods warehouses.

Responsible for site purchasing and planning functions, including the development of the site Supply Chain team to support those activities. Support the flow of products from Civica CMOs and private label distribution partners to Civica finished goods warehouses. Serve as the main point of contact for Civica 3PL warehouses.

Responsible for the timely mitigation of issues that prevent on time and in full delivery to customers. Support the implementation and compliance with Drug Supply Chain Security Act (DSCSA) requirements. This includes managing Civica serialization procedures, ensuring the proper flow of serialization data, mitigation of issues, and setup of new product launches.

Manages the Sales and Operations Planning (S&OP) process for the Civica Petersburg manufacturing site and supports Quarterly Business Reviews (QBRs) with CMOs, PLD partners, and 3PL providers. Supports the logistics of components and product to and from the manufacturing facility and 3PLs. Owns the relationship with Civica logistics providers.

Responsible for the overall Civica shipping validation program. Develops and maintains written procedures as it pertains to procurement, planning, logistics, serialization, warehousing, and distribution. Completes thorough root cause investigations and corrective actions for any deviations in a timely manner.

Supports site operations during regulatory/compliance audits. Basic Qualifications and Capabilities: Bachelor’s degree in related area and 10 years in Supply Chain Management, Operations, Project Management and/or Procurement in a cGMP environment.

Parenteral pharmaceutical experience preferred. Advanced computer applications skills (Excel, Word, Visio, ERPs, and PP). Experience in the use an ERP/ MRP is required. Excellent written and oral communication and presentation skills with the ability to speak and communicate effectively with both senior management and front-line staff personnel. Project Management, Operational Excellence, and/or Lean/Six Sigma experience preferred.